ATMPS

ATMPS is a UK health-tech company focused on software infrastructure for personalized medicine, especially cell and gene therapy workflows. Its core product, Hataali, is a patent-pending digital platform designed to manage chain-of-identity, chain-of-custody, scheduling, data sharing, and regulatory-compliant orchestration across hospitals, laboratories, manufacturers, and logistics providers. The company does not appear to be a drug developer; instead, it provides operational and interoperability technology for advanced therapy medicinal product pathways. ATMPS positions Hataali as an end-to-end, vein-to-vein platform for cell and gene therapies, stem cell therapies, and other advanced therapies, with compliance features such as GDPR/HIPAA support, auditability, and integration with MES/LIMS environments.